The number of people with susceptibility test result for rifampicin in Poland
Poland: The number of people with susceptibility test result for rifampicin was 91.55 in 2021. ▬ Flat
Latest (2021)
91.55
Change on year
up 1.4%
World rank
65th
of 146 countries
All-time high
91.55
in 2021
All-time low
89.51
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Poland, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Poland recorded 91.55 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 1.4% on the previous year and up 1.0% over five years.
That places Poland 65th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Poland, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 90.6 | — |
| 2018 | 89.8 | -0.9% |
| 2019 | 89.51 | -0.3% |
| 2020 | 90.25 | +0.8% |
| 2021 | 91.55 | +1.4% |
Poland compared with similar countries
- Poland's 91.55 is below the median for high income countries, which is 92.6, 99% of the median. (56 countries reporting)
- Poland's 91.55 is below the median for Europe & Central Asia, which is 93.52, 98% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 89.97 | 89.51 | 90.6 | 3 |
| 2020s | 90.9 | 90.25 | 91.55 | 2 |
Countries ranked near Poland
More health data for Poland
- Un projection of annual infant deaths, annual growth rate -1.23 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9071 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,693 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.59 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0201 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.49 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Poland?
- The number of people with susceptibility test result for rifampicin in Poland was 91.55 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Poland?
- The highest recorded value was 91.55 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Poland?
- The lowest recorded value was 89.51 in 2019.
- How does Poland rank for the number of people with susceptibility test result for rifampicin?
- Poland ranks 65th out of 146 countries with data for 2021.
- Where does this Poland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).